Changes in brain function during administration of venlafaxine or placebo to normal subjects

Duncan Mcgrouther, Andrew F. Leuchter, Ian A. Cook, David J. DeBrota, Aimee M. Hunter, William Z. Potter, Caroline C. McGrouther, Melinda L. Morgan, Michelle Abrams, Barbara Siegman

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Previous research has demonstrated neurophysiologic effects of antidepressants in depressed subjects. We evaluated neurophysiologic effects of venlafaxine in normal subjects. Healthy adults (n=32) received a 1-week placebo lead-in followed by 4 weeks randomized double-blind treatment with venlafaxine IR 150 mg. (n = 17) or placebo (n = 15). Brain function was examined using quantitative electroencephalographic (QEEG) power and theta cordance. Normal subjects receiving venlafaxine showed a decrease in theta-band cordance in the midline-and-right-frontal (MRF) region at 48 hours and at 1 week after randomization. Decreases in relative power also were seen in the MRF region; there were no significant changes in absolute power. These changes were significantly different from those in subjects receiving placebo. Changes in MRF cordance accurately identified treatment condition at 48 hours in 81.3% of subjects, and relative power from this region identified 60.7% of subjects. In conclusion, cordance may detect the pharmacological effects of antidepressant medication in normal subjects. Future studies should examine other classes of medication, as well as antidepressants with other mechanisms of action, to determine if cordance detects antidepressant medication effects in general in normal subjects.
    Original languageEnglish
    Pages (from-to)175-181
    Number of pages6
    JournalClinical EEG and Neuroscience
    Volume39
    Issue number4
    DOIs
    Publication statusPublished - Oct 2008

    Keywords

    • Cordance
    • Electroencephalography
    • Normal subjects
    • Placebo
    • Venlafaxine

    Fingerprint

    Dive into the research topics of 'Changes in brain function during administration of venlafaxine or placebo to normal subjects'. Together they form a unique fingerprint.

    Cite this